ReconAfrica Closes Oversubscribed Bought Deal, Turning Focus to Kavango West Production Tests

ReconAfrica raised CAD 21.9 million in an upsized bought deal to fund a horizontal sidetrack and production tests at Namibia's Kavango West 1X well.

ReconAfrica has wrapped up the public offering that will bankroll its next round of exploration work in Namibia, with the junior explorer confirming gross proceeds of roughly CAD 21.9 million from a bought-deal placement that was upsized more than once before landing.

The financing, announced Thursday, moved 29,932,200 units at CAD 0.73 apiece, with the underwriters exercising their over-allotment option in full. Each unit bundles one common share with half a warrant, and those warrants carry an exercise price of CAD 0.93 through September 10, 2029. The new securities are expected to begin trading on the TSX Venture Exchange under the ticker RECO.WT.D as early as next week.

Where the Money Goes

Proceeds are earmarked for the Kavango West 1X well (KW 1X), where the company intends to drill an open-hole horizontal sidetrack and run an extensive production testing program across the Huttenberg and Elandshoek formations. The plan calls for probing reservoir characteristics along a lateral section of up to 1,000 meters in the upper Huttenberg interval — work that builds on the vertical test phase, which already delivered reported natural gas and fluid flows to surface.

The offering did not come cheap. Underwriters collected a cash commission of about CAD 1.28 million, alongside more than 1.75 million broker warrants valid until September 2029.

Balance Sheet and Market Backdrop

The raise adds to a treasury that stood at CAD 24.2 million at the close of the second quarter, with warrant exercises during the first half already contributing just under CAD 4.97 million. Management also approved a fresh stock option program for executives roughly two weeks ago, a move widely read as an effort to tie leadership to the project's future performance.

Investors, however, greeted the formal close of the capital measure with selling. The stock dropped 7.4% on Friday to EUR 0.3745, leaving it 55% below its 52-week high of EUR 0.8360 set on January 14 and about 35% under its 200-day moving average. Pullbacks of this kind are commonplace among junior explorers once a large financing settles, as the new shares are booked and the capital base dilutes. The decline also extends a softer stretch: the operational update on KW 1X roughly three weeks ago was followed by a 12.5% share price slide, and the management option program preceded a further 12.9% drop.

What Hinges on the Tests

With the bought deal now closed, ReconAfrica has the financial runway to push ahead with its Namibian exploration campaign without leaning on additional partners in the near term. Even so, the risk profile for shareholders remains elevated — the outcome of the production tests at Kavango West 1X will ultimately determine how the market values the project.